Edition:
United States

China Resources Double-Crane Pharmaceutical Co Ltd (600062.SS)

600062.SS on Shanghai Stock Exchange

21.71CNY
2:59am EDT
Change (% chg)

¥-0.58 (-2.60%)
Prev Close
¥22.29
Open
¥22.29
Day's High
¥22.37
Day's Low
¥21.62
Volume
2,728,740
Avg. Vol
5,769,647
52-wk High
¥27.27
52-wk Low
¥20.64

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy 0.32 December 15 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 4 4 4 5
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.50 1.56

Consensus Estimates Analysis

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 1 1,923.67 1,923.67 1,923.67 1,704.88
Quarter Ending Dec-18 1 1,923.67 1,923.67 1,923.67 1,704.88
Year Ending Dec-18 7 7,351.21 7,689.00 6,887.00 6,744.99
Year Ending Dec-19 7 8,386.32 8,948.00 7,422.00 7,463.47
Earnings (per share)
Quarter Ending Sep-18 1 0.32 0.32 0.32 0.39
Quarter Ending Dec-18 1 0.32 0.32 0.32 0.39
Year Ending Dec-18 7 1.16 1.20 1.13 1.19
Year Ending Dec-19 7 1.36 1.43 1.30 1.37

Historical Surprises

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 1,442.75 2,137.80 695.05 48.18
Quarter Ending Dec-17 1,067.61 1,665.81 598.20 56.03
Quarter Ending Sep-17 1,403.22 1,680.15 276.93 19.74
Quarter Ending Jun-17 1,489.78 1,547.84 58.06 3.90
Quarter Ending Mar-17 1,373.81 1,528.05 154.24 11.23

Consensus Estimates Trend

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 1,923.67 1,923.67 1,923.67 1,923.67 1,704.88
Quarter Ending Dec-18 1,923.67 1,923.67 1,923.67 1,923.67 1,704.88
Year Ending Dec-18 7,351.21 7,351.21 7,351.21 7,351.21 6,744.99
Year Ending Dec-19 8,386.32 8,386.32 8,386.32 8,386.32 7,463.47

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings